The Role of Contraction and Relaxation in Facial Sculpting
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
Electrical muscle stimulation is often reduced to a single visual moment: the muscle contracts. In practice, useful stimulation is organized through time. An active phase recruits the muscle, and a release phase allows the tissue to return toward baseline before the next stimulus. That sequence is important for tolerability and repeated performance, but it should not be turned into claims about proven lymphatic drainage, oxygen delivery, healing, or an instant sculpted result.
PureLift uses PDM, the architecture combining Dynamic Modulation with Triple-Wave. Dynamic Modulation cycles through 361 frequencies across 1,370 to 1,730 Hz. Triple-Wave supplies low, mid, and high depth-oriented components. The complete waveform and delivered current determine the response. PDM is engineered to reduce accommodation relative to a fixed pattern, while the evidence supports modulation in general rather than a guaranteed PDM-specific clinical outcome.
What happens during the contraction phase
At an appropriate motor-level setting, electrical stimulation activates motor nerves and produces a visible muscle contraction. That is the physiological threshold that separates muscle work from a low-amplitude skin-support setting. The contraction is not valuable merely because it feels strong. It must be controlled, comfortable, and delivered with consistent contact in the correct treatment area.
Pro Plus and Glow reach up to 9 mA. Face, Pro, and Pro Edition use the same PDM engine with lower output, but their exact maxima are not supplied. Levels 1 and 2 do not add muscle activation. For any model, the target is a clear, tolerable engagement within the product directions. A painful or startling sensation is not evidence of a better session.
What the release phase contributes
When the stimulus eases, the muscle is no longer being held in the same activated state. That release allows the next contraction to begin from a different point in the cycle. In NMES research, duty cycle, frequency, pulse duration, intensity, electrode placement, and the amount of generated tension can all influence performance and fatigue. The release phase is therefore part of delivery design, not a beauty claim by itself.
It is tempting to describe release as pumping fluid or flushing tissue. The approved evidence does not establish that PureLift's contraction-relaxation cycle causes facial lymph movement or a specific circulation effect. Those ideas should not be inferred from the visible motion of the muscle. If a routine also includes gentle massage, describe that separately as lymphatic-drainage-style cosmetic support.
Why fixed and varied stimulation are different engineering choices
A fixed pattern repeatedly presents the nervous system and muscle with the same timing. Variable-frequency research shows that changing stimulation patterns can help sustain useful force or delay performance decline in certain protocols. Downey and colleagues studied a modulation strategy intended to extend the duration of effective NMES performance. The paper supports the general engineering importance of modulation, not a direct facial sculpting outcome or a trial of PureLift. See PMID 21996798.
Dynamic Modulation applies a proprietary randomized implementation across PureLift's operating band. The scientifically supported conclusion is narrower than the marketing shortcut. Modulation can outperform constant-frequency stimulation in relevant performance contexts. It does not mean that a user can never adapt, that every contraction stays identical, or that results cannot plateau. The companion article Why the Contraction-Relaxation Cycle Matters develops the delivery principle in more detail.
What facial NMES evidence adds
Kavanagh and colleagues provide a facial muscle outcome that is more directly relevant than general rehabilitation studies. Their randomized controlled trial included 108 women using a defined facial NMES protocol. At twelve weeks, the mean zygomaticus major thickness increased by 18.6 percent in the intervention group, measured by ultrasound. The source is PMID 23174048.
That result is category-level evidence. The intervention was not presented as a PureLift PDM trial, and the study does not establish that the contraction-relaxation pattern alone caused every cosmetic observation. It also cannot provide a guaranteed schedule for an individual. The useful conclusion is that a defined facial NMES protocol produced a measured muscle endpoint under controlled research conditions.
Why Omatsu must be kept in a separate evidence box
Omatsu 2024 is sometimes cited as if it were a second facial-NMES-only muscle trial. The combined design cannot isolate facial NMES. It was a prospective split-face controlled study, not a randomized trial. The multimodal device combined 40 to 190 kHz facial NMES, iontophoresis, LED, and cooling. Its cosmetic and blood-flow endpoints were measured at week eight. The study did not measure facial muscle thickness, the SMAS, lymphatic flow, or a PureLift contraction cycle. The original record is PMID 38992992.
The 2026 correction disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments. It said the results and conclusions were unchanged. The correction appears at PMID 41834264. Any discussion must therefore identify the combined modalities and commercial relationships. The paper cannot prove that facial NMES, PDM, or contraction-relaxation cycling independently caused its outcomes.
How to recognize a well-run session
A productive session is technically consistent. The skin has suitable conductive product, the treatment head maintains contact, placement follows the instructions, and output is raised only to comfortable visible engagement. The user is not compensating with excessive pressure or speeding through the treatment. If contact breaks or the skin dries, the sensation may become sharp without improving muscle recruitment.
Progress assessment should be equally controlled. Use photographs with similar light, distance, expression, and time of day. Note the model, setting, comfort, and whether contraction was visible. Research periods such as twelve weeks are contexts for a particular study, not a promise that a specific contour appears on a specific day. A routine should be judged over repeated, comparable observations.
Release is not a medical recovery claim
The relaxation portion of an electrical cycle is sometimes described with language borrowed from sports recovery. That analogy can be useful for understanding timing, but it does not prove that a facial session repairs tissue, removes metabolic waste, or creates a therapeutic recovery response. In this context, release simply describes the interval in which the evoked contraction eases before the next stimulus. The evidence-based advantage is orderly repeated muscle engagement. Any broader biological claim would require a study that directly measured that outcome under the PureLift protocol.
The same caution applies to comfort. A smoother-feeling pattern can make a routine easier to use, yet comfort is individual and no direct consumer-device trial establishes that PDM is more comfortable than every fixed-frequency alternative. Describe the engineering choice, record the user's experience, and avoid converting preference into a clinical result.
The honest sculpting claim
Contraction and release are essential parts of an EMS delivery pattern because they organize repeated muscle engagement. Modulation can improve performance relative to a fixed pattern in relevant NMES research. Facial NMES has category-level evidence for a measured muscle endpoint. Those facts support a technically serious facial-fitness routine. They do not prove immediate sculpting, lymphatic drainage, enhanced oxygen, or a guaranteed cosmetic result.